Finance News – Cvs
What is your interest today?
Tariffs
Ceo
Investors
Stock
Earnings
Shares
Markets
Stocks
China
Trade
Investment
Revenue
Nasdaq
Economy
Wall street
Eqs
Stock market
Warren buffett
Berkshire hathaway
Trade war
Prices
Nvidia
Inflation
Cet
Securities
Class action
U.s.
Company
Amazon
Apple
Guidance
Sales
Federal reserve
S&p 500
Bitcoin
Ipo
Trading
Corporate
Crypto
Recession
Tesla
Forecast
Microsoft
Companies
Interest rates
Gold
Shareholders
Walmart
Imports
Business
Defensive
Federal open market committee
Interim reporting
Deals partner
Coterra
Tfi international inc
Guidances
Guidelines
Credit-card debt
Deficit
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0
px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400
text-gray-900 dark:text-gray-100 mr-2"
/>
CNBC Business • May 01, 2025
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS has raised its full-year earnings forecast to between $6 and $6.20 per share due to positive developments in its insurance sector, surpassing previous expectations.
Read Full Article →
CNBC Business • May 01, 2025
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Starting July 1, Caremark will prioritize Wegovy on its formulary, improving accessibility for patients on its drug plans and potentially increasing the treatment's market presence...
Read Full Article →